About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Infectious Disease Molecular Diagnostics Market Size, Trends & Demand by 2031
Infectious Disease Molecular Diagnostics Market

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Applications (Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Disease, Other Infectious Diseases), By Technology (Polymerase chain reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others), By End-User (Hospitals, Clinics, Diagnostics Laboratories, Research Institutes) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI55442DR
Last Updated : November 28, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Infectious Disease Molecular Diagnostics Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents
          1. By Value
        4. Services
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Respiratory Diseases
          1. By Value
        3. Tuberculosis
          1. By Value
        4. Meningitis
          1. By Value
        5. Gastrointestinal Tract Infections
          1. By Value
        6. HPV
          1. By Value
        7. Sexually Transmitted Infections
          1. By Value
        8. Sepsis
          1. By Value
        9. Drug Resistance Disease
          1. By Value
        10. Other Infectious Diseases
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. In Situ Hybridization
          1. By Value
        4. Isothermal Nucleic Acid Amplification Technology (INAAT)
          1. By Value
        5. Chips and Microarrays
          1. By Value
        6. Mass Spectrometry
          1. By Value
        7. Sequencing
          1. By Value
        8. Transcription Mediated Amplification
          1. By Value
        9. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinics
          1. By Value
        4. Diagnostics Laboratories
          1. By Value
        5. Research Institutes
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents
          1. By Value
        4. Services
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Respiratory Diseases
          1. By Value
        3. Tuberculosis
          1. By Value
        4. Meningitis
          1. By Value
        5. Gastrointestinal Tract Infections
          1. By Value
        6. HPV
          1. By Value
        7. Sexually Transmitted Infections
          1. By Value
        8. Sepsis
          1. By Value
        9. Drug Resistance Disease
          1. By Value
        10. Other Infectious Diseases
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. In Situ Hybridization
          1. By Value
        4. Isothermal Nucleic Acid Amplification Technology (INAAT)
          1. By Value
        5. Chips and Microarrays
          1. By Value
        6. Mass Spectrometry
          1. By Value
        7. Sequencing
          1. By Value
        8. Transcription Mediated Amplification
          1. By Value
        9. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinics
          1. By Value
        4. Diagnostics Laboratories
          1. By Value
        5. Research Institutes
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents
          1. By Value
        4. Services
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Respiratory Diseases
          1. By Value
        3. Tuberculosis
          1. By Value
        4. Meningitis
          1. By Value
        5. Gastrointestinal Tract Infections
          1. By Value
        6. HPV
          1. By Value
        7. Sexually Transmitted Infections
          1. By Value
        8. Sepsis
          1. By Value
        9. Drug Resistance Disease
          1. By Value
        10. Other Infectious Diseases
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. In Situ Hybridization
          1. By Value
        4. Isothermal Nucleic Acid Amplification Technology (INAAT)
          1. By Value
        5. Chips and Microarrays
          1. By Value
        6. Mass Spectrometry
          1. By Value
        7. Sequencing
          1. By Value
        8. Transcription Mediated Amplification
          1. By Value
        9. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinics
          1. By Value
        4. Diagnostics Laboratories
          1. By Value
        5. Research Institutes
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Singapore
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents
          1. By Value
        4. Services
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Respiratory Diseases
          1. By Value
        3. Tuberculosis
          1. By Value
        4. Meningitis
          1. By Value
        5. Gastrointestinal Tract Infections
          1. By Value
        6. HPV
          1. By Value
        7. Sexually Transmitted Infections
          1. By Value
        8. Sepsis
          1. By Value
        9. Drug Resistance Disease
          1. By Value
        10. Other Infectious Diseases
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. In Situ Hybridization
          1. By Value
        4. Isothermal Nucleic Acid Amplification Technology (INAAT)
          1. By Value
        5. Chips and Microarrays
          1. By Value
        6. Mass Spectrometry
          1. By Value
        7. Sequencing
          1. By Value
        8. Transcription Mediated Amplification
          1. By Value
        9. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinics
          1. By Value
        4. Diagnostics Laboratories
          1. By Value
        5. Research Institutes
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents
        1. By Value
      4. Services
        1. By Value
    3. By Applications
      1. Introduction
        1. Applications By Value
      2. Respiratory Diseases
        1. By Value
      3. Tuberculosis
        1. By Value
      4. Meningitis
        1. By Value
      5. Gastrointestinal Tract Infections
        1. By Value
      6. HPV
        1. By Value
      7. Sexually Transmitted Infections
        1. By Value
      8. Sepsis
        1. By Value
      9. Drug Resistance Disease
        1. By Value
      10. Other Infectious Diseases
        1. By Value
    4. By Technology
      1. Introduction
        1. Technology By Value
      2. Polymerase chain reaction (PCR)
        1. By Value
      3. In Situ Hybridization
        1. By Value
      4. Isothermal Nucleic Acid Amplification Technology (INAAT)
        1. By Value
      5. Chips and Microarrays
        1. By Value
      6. Mass Spectrometry
        1. By Value
      7. Sequencing
        1. By Value
      8. Transcription Mediated Amplification
        1. By Value
      9. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Clinics
        1. By Value
      4. Diagnostics Laboratories
        1. By Value
      5. Research Institutes
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents
          1. By Value
        4. Services
          1. By Value
      2. By Applications
        1. Introduction
          1. Applications By Value
        2. Respiratory Diseases
          1. By Value
        3. Tuberculosis
          1. By Value
        4. Meningitis
          1. By Value
        5. Gastrointestinal Tract Infections
          1. By Value
        6. HPV
          1. By Value
        7. Sexually Transmitted Infections
          1. By Value
        8. Sepsis
          1. By Value
        9. Drug Resistance Disease
          1. By Value
        10. Other Infectious Diseases
          1. By Value
      3. By Technology
        1. Introduction
          1. Technology By Value
        2. Polymerase chain reaction (PCR)
          1. By Value
        3. In Situ Hybridization
          1. By Value
        4. Isothermal Nucleic Acid Amplification Technology (INAAT)
          1. By Value
        5. Chips and Microarrays
          1. By Value
        6. Mass Spectrometry
          1. By Value
        7. Sequencing
          1. By Value
        8. Transcription Mediated Amplification
          1. By Value
        9. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Clinics
          1. By Value
        4. Diagnostics Laboratories
          1. By Value
        5. Research Institutes
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Infectious Disease Molecular Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Becton, Dickinson and Company
    3. biome Rieux SA
    4. Bio-Rad Laboratories, Inc.
    5. Agilent Technologies, Inc.
    6. Danaher Corporation
    7. Hologic, Inc. (Gen-Probe)
    8. Illumina, Inc.
    9. Grifols S.A.
    10. Qiagen
    11. F. Hoffmann-La Roche Ltd
    12. Siemens Healthiness AG
    13. Sysmex Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global infectious disease diagnostics market was valued at USD 41.79 billion in 2022. It is expected to reach USD 57.91 billion by 2031, growing at a CAGR of 3.69% during the forecast period (2023–2031). Infectious illness, a diagnosis is
Buy Now
Global Report
Infectious Disease Testing Market Insights The global infectious disease testing market size was valued at USD 24.2 billion in 2022 and is projected to reach USD 41.5 billion by 2031, growing at a CAGR of 6.2% during the forecast period (2023–
Buy Now
Global Report
Infectious Respiratory Disease Diagnostics Market Size The global infectious respiratory disease diagnostics market size was valued at USD 24 billion in 2022 and is projected to reach USD 38.86 billion by 2031, growing at a 
Buy Now
Global Report
Point-Of-Care Molecular Diagnostics Market Size The global point-of-care molecular diagnostics market size was valued at USD 2.27 billion in 2022 and is projected to reach USD 4.48 billion by 2031, growing at a CAGR of 7.84% 
Buy Now
Global Report
The global veterinary infectious disease diagnostics market size was valued at USD 1.93 billion in 2022. It is estimated to reach USD 3.95 billion by 2031, growing at a CAGR of 8.49% during the forecast period (2023–2031). Veterinary infectiou
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.